MannKind building out inhaler plant; FDA and customs make importing easier for secure companies;

> The FDA and Customs and Border Protection (CBP) have launched the "Trusted Trader" to expedite imports by companies that show they have secure supply chains. Story

> India's Granules reported to markets that its paracetamol manufacturing facility in Andhra Pradesh passed a U.S. FDA inspection without any 483 observations. Report

> India-based pharmaceutical distribution company Vasu Group has turned to Akums Drugs and Pharmaceuticals as its manufacturer as it moves into pharmaceutical formulation. Story

> India turned back an effort in the World Health Organization to establish new manufacturing standards for participants in its programs. Story

> MannKind ($MNKD) COO Hakan Edstrom said at the company is building out its plant in Danbury, CT, while it awaits FDA approval of its inhaled insulin product, Afrezza. Transcript

> The FDA last week sent a warning letter to Tianjin Zhongan Pharmaceutical in Tianjin, China outlining a host of manufacturing issues. Warning Letter

And Finally... Jubilant HollisterStier, which last year received two FDA warning letters for problems with two North American plants, has named a new CEO, Bill Simmons, who comes to the Indian-owned company from a consulting position. Report